CellOxess Biotechnology

CellOxess is a private U.S. biotechnology company focused on measuring and mitigating oxidative stress, with particular emphasis on reproductive health. The company is developing bio-analytical assays to characterize redox-related biomarkers and support clinical decision-making, especially in assisted reproduction settings. It also markets and develops natural antioxidant and nutraceutical formulations intended to restore cellular redox balance and support systemic health. Publicly visible pipeline activity appears concentrated in male reproductive health, including Fertilix, an antioxidant supplement studied for sperm oxidative DNA damage. CellOxess also highlights academic collaborations and research spanning cardiovascular, metabolic, neurological, and reproductive health applications.